{"id":"W2161254226","doi":"10.1007/s00467-011-1894-x","title":"Should we consider MMF therapy after rituximab for nephrotic syndrome?","year":2011,"lang":"en","type":"letter","venue":"Pediatric Nephrology","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Rituximab; Nephrology; Nephrotic syndrome; Cyclophosphamide; Mycophenolate; Internal medicine; Drug; Clinical trial; Intensive care medicine; Maintenance therapy; Oncology; Pharmacology; Chemotherapy; Transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001988079,0.000824909,0.00171052,0.0007263959,0.0001091476,0.00003885253,0.0002829138,0.001937651,0.003214089],"category_scores_gemma":[0.0001139117,0.0006556196,0.000910168,0.0003260901,0.000294838,0.00009091862,0.0001041673,0.001774876,0.0007085807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006873495,"about_ca_system_score_gemma":0.0004741068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005363502,"about_ca_topic_score_gemma":0.000005374632,"domain_scores_codex":[0.9963604,0.0001735147,0.0007791034,0.001033652,0.0004541164,0.001199235],"domain_scores_gemma":[0.9975728,0.0006031264,0.0003539127,0.0009361843,0.0002729235,0.0002610105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001350525,0.0002910542,0.003595478,0.001514616,0.0004626952,0.005657235,0.00009490339,1.556696e-7,0.000009196987,0.00002113053,0.9857768,0.001226207],"study_design_scores_gemma":[0.004821141,0.001423712,0.01396748,0.00004359762,0.002369442,0.001788827,0.000007910396,0.000006091588,0.000005303307,0.003145685,0.9717345,0.0006863605],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.07435526,0.1149479,0.0002487784,0.8012941,0.002509813,0.004838341,0.0007502318,0.0003901019,0.0006654128],"genre_scores_gemma":[0.01502115,0.02143072,0.000985023,0.941524,0.01495953,0.00178824,0.0005372179,0.0002754854,0.0034786],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.1402299,"threshold_uncertainty_score":0.9995895,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04435941131371676,"score_gpt":0.2839114140383888,"score_spread":0.239552002724672,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}